Loading Events

« All Events

  • This event has passed.

Oct 24th: Olivier Adotevi

24 October 2019 @ 15 h 30 min - 16 h 30 min UTC+1

Olivier Adotevi

Regional Institute of Cancer, University Hospital of BESANCON
Immunomolecular Therapies in Cancer, INSERM UMR1098

Title: ” Prospects of telomerase-specific CD4 T cell responses in anti-cancer immunotherapy ”

Abstract: CD4 + Th1 cells play a critical role in tumor immunosurveillance by orchestrating cell-
mediated immunity against cancer cells. Furthermore, evidence indicates that triggering
appropriate CD4 + T cells can significantly increase cancer immunotherapy efficacy. These
properties highlight the interest of finding ways to harness the clinical potential of CD4 + T
cells. By using telomerase (TERT) as a prototype of shared tumor-associated antigen, our
team develops a research program that aims to study the regulation and clinical significance
of tumor-reactive CD4 Th1 response in peripheral blood. We also initiated an innovative
anticancer vaccine project using TERT-derived helper peptides designated to stimulate CD4
Th1 responses in vivo.





Salle de conférences IBGC


Immuno ConcEpT


24 October 2019
15 h 30 min - 16 h 30 min UTC+1
Event Category: